Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-30 4:43 pm Purchase |
2023-03-23 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 624,847 15.400% |
299,431 (+92.01%) |
Filing History |
| 2023-03-29 4:27 pm Purchase |
2023-03-23 | 13D | Harpoon Therapeutics, Inc. HARP |
Arix Bioscience plc | 323,893 8.400% |
104,801 (+47.83%) |
Filing History |
| 2023-02-14 4:25 pm Sale |
2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 80,421 2.400% |
-86,369 (-51.78%) |
Filing History |
| 2023-02-06 4:32 pm Purchase |
2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 325,416 9.800% |
4,231 (+1.32%) |
Filing History |
| 2023-01-18 4:16 pm Purchase |
2023-01-12 | 13G | Harpoon Therapeutics, Inc. HARP |
Integrated Core Strategies (US) LLC | 197,027 5.900% |
197,027 (New Position) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Harpoon Therapeutics, Inc. HARP |
BLACKROCK INC BLK |
94,048 2.800% |
-77,386 (-45.14%) |
Filing History |
| 2022-02-15 08:37 am Sale |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 150,000 4.600% |
-33,000 (-18.03%) |
Filing History |
| 2022-02-11 4:58 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
New Leaf Ventures III L.P. | 321,186 9.800% |
28,553 (+9.76%) |
Filing History |
| 2022-02-11 4:26 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 166,790 5.100% |
64,720 (+63.41%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BLACKROCK INC BLK |
171,433 5.200% |
31,903 (+22.86%) |
Filing History |
| 2021-12-27 5:25 pm Purchase |
2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 183,000 5.600% |
183,000 (New Position) |
Filing History |
| 2021-07-15 5:41 pm Sale |
2021-07-06 | 13D | Harpoon Therapeutics, Inc. HARP |
Arix Bioscience plc | 219,092 6.700% |
-1,775 (-0.80%) |
Filing History |
| 2021-05-06 06:15 am Sale |
2021-04-30 | 13D | Harpoon Therapeutics, Inc. HARP |
MPM BioVentures 2014, L.P. | 656,146 20.200% |
-57,527 (-8.06%) |
Filing History |
| 2021-02-16 08:30 am Sale |
2021-01-27 | 13D | Harpoon Therapeutics, Inc. HARP |
MPM BioVentures 2014, L.P. | 713,673 22.300% |
-128,612 (-15.27%) |
Filing History |
| 2021-02-12 4:49 pm Sale |
2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 102,070 4.020% |
-34,000 (-24.99%) |
Filing History |
| 2021-02-10 3:04 pm Purchase |
2021-01-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BLACKROCK INC BLK |
139,531 4.400% |
3,109 (+2.28%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
BLACKROCK INC BLK |
136,421 5.400% |
136,421 (New Position) |
Filing History |
| 2021-01-12 4:15 pm Purchase |
2021-01-11 | 13D | Harpoon Therapeutics, Inc. HARP |
Arix Bioscience plc | 220,867 6.900% |
1,496 (+0.68%) |
Filing History |
| 2020-06-01 5:00 pm Sale |
2020-05-27 | 13D | Harpoon Therapeutics, Inc. HARP |
Arix Bioscience plc | 219,370 8.800% |
-41,521 (-15.92%) |
Filing History |